Shirley, NY (June 27, 2013) – Luitpold Animal Health, a division of Luitpold Pharmaceuticals, Inc., manufacturers of Adequan® IM, Adequan® IA, and Adequan® Canine provide the following supply interruption update:
Luitpold’s NY facility has undergone significant renovations and upgrades to meet enhanced quality standards and address observations made by the U.S. Food and Drug Administration (FDA). These renovations required cessation of manufacturing and affected Luitpold’s ability to release product. This has resulted in shortages in the marketplace. Luitpold has worked in recent months to optimally allocate inventory and manage the limited remaining supply, which has now been depleted.
Luitpold remains committed to resuming its manufacture and release of Adequan® products. We understand how critically important the Adequan® brands are to the health and well-being of the animals receiving treatment. The company’s latest expectations for reestablishing Adequan® supply to the market is estimated to be first quarter 2014 however, this hinges upon completion of a successful inspection by the FDA.
The company has established a dedicated webpage on www.adequan.com where concerned parties can register to receive future communications and updates on this matter. You may also contact our Customer Service Department at 1-800-458-0163.
During this supply interruption, we strongly recommend Veterinarians work together with equine and canine owners and caregivers to evaluate and decide upon the safest and most effective alternative treatments.
Adequan® IM and IA are the only polysulfated glycosaminoglycan (PSGAG) approved by the FDA for the treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness in horses. Adequan® Canine is the only polysulfated glycosaminoglycan (PSGAG) approved by the FDA for the control of signs associated with non-infectious degenerative and/or traumatic arthritis of canine synovial joints.
The United States Eventing Association, Inc. (USEA) is pleased to announce #WeRideTogether is returning as an “Official Educational Partner of the USEA,” “Contributing Sponsor of the American Eventing Championships,” “Contributing Sponsor of the Intercollegiate and Interscholastic Championships,” and “Contributing Sponsor of the EA21 Program.”
The 2024 USEA Intercollegiate & Interscholastic Eventing Championships were an incredible success, marking a new era of partnership for the two programs which aim to encourage the USEA’s junior and young adult members to continue to pursue their passion for eventing throughout their educational years and beyond.
On this week's edition of the USEA Podcast, interim podcast host Rosie Russell touches base with this year's Defender/USEF CCI5*-L National Champion Lauren Nicholson who was the highest-placed U.S. rider in the 2024 Defender Kentucky Three-Day Event. Rosie talks with Lauren about her history with her longtime partner Vermiculus, their preparations for Kentucky, their outstanding performance at the five-star event, and so much more!
After an action packed Saturday at Stable View on the opening day of the 8th Annual USEA Intercollegiate Eventing National Championship, the podium was up for grabs heading into the final day of competition. The stage was set for an unforgettable showdown between the 18 university and college teams who were entered.